Joint Healthcare Industry Paper - The value of industry involvement in HTA
What is the aim of HTA?
According to the EUnetHTA definition1, health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective health policies that are patient focused and seek to achieve best value.
Sound and transparent HTA, with proper involvement of patients, health care professionals and industry can support: i) efficient decision-making, ii) efficient allocation of resources, and iii) informed uptake and diffusion of health technology.
Whenever required, HTA complements the information available on the performance of the technology as specified in its label (assessed by regulatory agencies) by providing insight in the value of the technology for healthcare and society, considering multiple aspects, in the context of a specific healthcare system.
If correctly carried out, HTA is also a useful tool to encourage and reward innovation with the greatest value to patients and society.
Why involve the healthcare industry in HTA?
The healthcare industry believes it can be a valuable partner in the overall HTA process, acknowledging agencies must retain their independence in providing advice to payers and governments.
Most systems have evolved over time and strive to increase industry engagement, both at the policy level with representative associations and in specific technology assessment processes with manufacturers. This evolution is crucial as it will lead to system and methods improvements.